Elsevier Inc.

SHERPA: Unknown

People

  1. Palomba
    Palomba
  2. Horwitz
    Horwitz
  3. Zelenetz
    Zelenetz
  4. Perales
    Perales
  5. Giralt
    Giralt
  6. Shah
    Shah
  7. Dahi
    Dahi
  8. Yahalom
    Yahalom
  9. Moskowitz
    Moskowitz
  10. Scordo
    Scordo

Groups

  1. Center for Hematologic Malignancies (187)
  2. Department of Medicine (187)
  3. Hematologic Malignancies, Division of (187)
  4. Lymphoma (187)
  5. Survivorship Research (70)
  6. Bone Marrow Transplant (43)
  7. Population Sciences Research Program (37)
  8. Epidemiology and Biostatistics (32)
  9. Biostatistics Service (29)
  10. CTCR Scholars (28)
Search Within
  1. "Lymphoma"
Formats
  1. Meeting Abstract (92)
  2. Journal Article (79)
  3. Editorial (7)
  4. Review (5)
  5. Conference Paper (2)
  6. Book Section (1)
  7. Guidelines (1)
Groups
  1. Center for Hematologic Malignancies (187)
  2. Department of Medicine (187)
  3. Hematologic Malignancies, Division of (187)
  4. Lymphoma (187)
  5. Survivorship Research (70)
  6. Bone Marrow Transplant (43)

More Groups

People
  1. Maria Palomba (44)
  2. Steven Horwitz (33)
  3. Craig Sauter (31)
  4. Andrew Zelenetz (30)
  5. Miguel-Angel Perales (29)
  6. Matthew Matasar (28)

More People

Years
  1. 2025 (3)
  2. 2024 (5)
  3. 2023 (7)
  4. 2022 (26)
  5. 2021 (17)
  6. 2020 (21)

More Years

Publications
  1. Clinical Lymphoma, Myeloma and Leukemia (63)
  2. Biology of Blood and Marrow Transplantation (38)
  3. International Journal of Radiation Oncology, Biology, Physics (18)
  4. Transplantation and Cellular Therapy (13)
  5. European Journal of Cancer (12)
  6. Hematology/Oncology Clinics of North America (8)

More Publications

Results (187)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Magnesium for T cells: Strong to the finish!
    Editorial

    Vardhana, S.; Dustin, M. L.
    Trends in Immunology (2022)

    Fulltext@MSK | Save
  • IVAC with or without rituximab for relapsed or refractory B-cell non-Hodgkin lymphomas: Real-world experience in the modern era
    Journal Article

    Buege, M. J.; Dao, P. H.; Drill, E.; LeVoir, A.; Pak, T.; Peterson, T. J.; Straus, D. J.
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • A proof-of-principle study of split-course bridging radiotherapy prior to commercial CD19 CAR T-cell therapies for patients with relapsed or refractory B-cell lymphomas
    Meeting Abstract

    Imber, B. S.; Palomba, M. L.; Yahalom, J.
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • Characterization and outcomes in patients with mogamulizumab-associated skin reactions in the MAVORIC trial
    Meeting Abstract

    Musiek, A. C. M.; Whittaker, S.; Horowitz, S. M.; Bagot, M.; Huen, A.; Fisher, D. C.; Haun, P.; Vermeer, M. H.; Ito, T.; Dwyer, K.; more...
    European Journal of Cancer (2021)

    Fulltext@MSK | Save
  • Time-to-next-treatment and time-to-next-systemic treatment in patients included in the PROCLIPI registry
    Meeting Abstract

    Quaglino, P.; Ortiz-Romero, P.; Bagot, M.; Cozzio, A.; Evison, F.; Geskin, L.; Guenova, E.; Hodak, E.; Horwitz, S.; Papadavid, E.; more...
    European Journal of Cancer (2021)

    Fulltext@MSK | Save
  • Metabolic regulation of the cancer-immunity cycle
    Editorial

    Somarribas Patterson, L. F.; Vardhana, S. A.
    Trends in Immunology (2021)

    Fulltext@MSK | Save
  • Feasibility of combining the phosphatidylinositol 3-kinase inhibitor copanlisib with rituximab-based immunochemotherapy in patients with relapsed indolent B-cell lymphoma
    Journal Article

    Matasar, M. J.; Dreyling, M.; Leppä, S.; Santoro, A.; Pedersen, M.; Buvaylo, V.; Fletcher, M.; Childs, B. H.; Zinzani, P. L.
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • T cells critically depend on pyruvate oxidation
    Editorial

    Schrecker, C.; Intlekofer, A. M.
    Cell Metabolism (2021)

    Fulltext@MSK | Save
  • Updated experience from mosunetuzumab in multiple relapsed follicular lymphoma: Promising efficacy from a phase I trial
    Meeting Abstract

    Assouline, S.; Kim, W. S.; Sehn, L. H.; Schuster, S. J.; Cheah, C. Y.; Nastoupil, L. J.; Shadman, M.; Yoon, S. S.; Matasar, M. J.; Diefenbach, C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • The ECHELON-2 trial: 5-year results of a randomized, double-blind, phase 3 study of brentuximab vedotin and CHP (A+CHP) versus CHOP in frontline treatment of patients with CD30-positive peripheral T-cell lymphoma
    Meeting Abstract

    Iyer, S.; Trümper, L.; O'Connor, O. A.; Pro, B.; Illidge, T.; Advani, R.; Bartlett, N. L.; Christensen, J. H.; Morschhauser, F.; Domingo-Domenech, E.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save